Establishment Labs (NASDAQ: ESTA) net income
Establishment Labs reported a net loss of $51.1m for fiscal 2025; in fiscal 2024 it reported a net loss of $84.6m. Earnings per share were −$1.72.
Establishment Labs's best year of the last 9 was fiscal 2018. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$51.1m | — | −24.2% | −$1.72 |
| 2024 | −$84.6m | — | −51.0% | −$3.00 |
| 2023 | −$78.5m | — | −47.5% | −$3.07 |
| 2022 | −$75.2m | — | −46.5% | −$3.08 |
| 2021 | −$41.1m | — | −32.5% | −$1.72 |
| 2020 | −$38.1m | — | −45.0% | −$1.63 |
| 2019 | −$38.2m | — | −42.6% | −$1.86 |
| 2018 | −$21.1m | — | −34.5% | — |
| 2017 | −$34.9m | — | −100.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Establishment Labs net income compared with its sector
By net income for its latest fiscal year, Establishment Labs ranks 258th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Establishment Labs, −24.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 256th | Lexicon Pharmaceuticals | −$50.3m | −101.1% |
| 257th | Sagimet Biosciences | −$51.0m | — |
| 258th | Establishment Labs | −$51.1m | −24.2% |
| 259th | Evolus | −$51.6m | −17.4% |
| 260th | Invivyd | −$52.5m | −98.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Establishment Labs
- How much did Establishment Labs earn in fiscal 2025?
- Establishment Labs reported a net loss of $51.1m for fiscal 2025. In fiscal 2024 it reported a net loss of $84.6m.
- What are the earnings per share of Establishment Labs?
- They were −$1.72 in fiscal 2025, compared with −$3.00 in fiscal 2024.
- Where does Establishment Labs rank in its sector by net income?
- It ranks 258th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Establishment Labs come from?
- From the annual report (Form 10-K) that Establishment Labs files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Establishment Labs files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Establishment Labs: the Establishment Labs page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.